Idan Goren

Appearances

DYSPLASIA DETECTION RATES IN A SURVEILLANCE PROGRAM REAL-WORLD DATA FROM A TERTIARY REFERRAL CENTER FOR INFLAMMATORY BOWEL DISEASES
Date
May 9, 2023
BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
Presenter
Yifat Snir
Speakers
Jacob Ollech
Noam Peleg
Irit Avni-Biron
Hagar Banai-Eran
Yelena Broitman
Tali Sharar-Fischler
Idan Goren
Zohar Levi
Iris Dotan
Tel Aviv Sourasky Medical Center
Henit Yanai
INTEGRIN INHIBITION REDUCES PROFIBROTIC RESPONSES IN CROHN’S DISEASE (CD) HUMAN INTESTINAL MYOFIBROBLASTS IN VITRO AND AMELIORATES EXPERIMENTAL INTESTINAL FIBROSIS IN VIVO - A POTENTIAL NOVEL APPROACH TO CD STRICTURE THERAPY
Date
May 21, 2024
_INTRODUCTION:_ Despite effective anti-inflammatory therapies, ~70% of CD patients require surgery in their lifetime, due to fibrostenotic strictures linked to excess extracellular matrix (ECM) deposition…
Presenter
Pranab Mukherjee
Speakers
Doug Czarnecki
Jyotsna Chandra
Shaomin Hu
Quang Tam Nguyen
Weiwei Liu
William Massey
Yan Wang
Jamie Wong
Min Liu
Gail West
Suhanti Banerjee
Idan Goren
Florian Rieder
Cleveland Clinic Foundation